RLFTY
Price
$2.97
Change
+$0.14 (+4.95%)
Updated
Jun 27 closing price
Capitalization
33.54M
TARS
Price
$40.35
Change
+$0.02 (+0.05%)
Updated
Jun 27 closing price
Capitalization
1.7B
39 days until earnings call
Interact to see
Advertisement

RLFTY vs TARS

Header iconRLFTY vs TARS Comparison
Open Charts RLFTY vs TARSBanner chart's image
RELIEF THERAPEUTICS HLDG AG
Price$2.97
Change+$0.14 (+4.95%)
Volume$155
Capitalization33.54M
Tarsus Pharmaceuticals
Price$40.35
Change+$0.02 (+0.05%)
Volume$951.83K
Capitalization1.7B
RLFTY vs TARS Comparison Chart in %
Loading...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLFTY vs. TARS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLFTY is a Hold and TARS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (RLFTY: $2.97 vs. TARS: $40.35)
Brand notoriety: RLFTY and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLFTY: 22% vs. TARS: 146%
Market capitalization -- RLFTY: $33.66M vs. TARS: $1.7B
RLFTY [@Biotechnology] is valued at $33.66M. TARS’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLFTY’s FA Score shows that 1 FA rating(s) are green whileTARS’s FA Score has 0 green FA rating(s).

  • RLFTY’s FA Score: 1 green, 4 red.
  • TARS’s FA Score: 0 green, 5 red.
According to our system of comparison, both RLFTY and TARS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLFTY’s TA Score shows that 2 TA indicator(s) are bullish while TARS’s TA Score has 5 bullish TA indicator(s).

  • RLFTY’s TA Score: 2 bullish, 5 bearish.
  • TARS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TARS is a better buy in the short-term than RLFTY.

Price Growth

RLFTY (@Biotechnology) experienced а -1.00% price change this week, while TARS (@Biotechnology) price change was -0.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

TARS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARS($1.7B) has a higher market cap than RLFTY($33.5M). TARS YTD gains are higher at: -27.127 vs. RLFTY (-39.388).
RLFTYTARSRLFTY / TARS
Capitalization33.5M1.7B2%
EBITDAN/A-94.96M-
Gain YTD-39.388-27.127145%
P/E RatioN/AN/A-
RevenueN/A234M-
Total CashN/A408M-
Total DebtN/A72.4M-
TECHNICAL ANALYSIS
Technical Analysis
RLFTYTARS
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
39%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
41%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBFAX33.860.27
+0.80%
Neuberger Berman Focus Adv
FBKFX16.650.05
+0.30%
Fidelity Balanced K6
RAACX9.990.02
+0.20%
Altegris/AACA Opportunistic Real Estt C
SUVCX10.600.02
+0.19%
PGIM Quant Solutions Large-Cap Val C
HBLAX14.62N/A
N/A
Hartford Balanced Income A

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
+4.95%
RLFTF - RLFTY
47%
Loosely correlated
N/A
AMLX - RLFTY
25%
Poorly correlated
N/A
ORKA - RLFTY
24%
Poorly correlated
-4.73%
SNGX - RLFTY
22%
Poorly correlated
-0.73%
TARS - RLFTY
22%
Poorly correlated
+0.05%
More

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with ADMA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then ADMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
+0.05%
ADMA - TARS
42%
Loosely correlated
-1.30%
RYTM - TARS
38%
Loosely correlated
+2.09%
CRNX - TARS
37%
Loosely correlated
-0.10%
OCUL - TARS
37%
Loosely correlated
-2.54%
ETNB - TARS
36%
Loosely correlated
-0.90%
More